Oxidized thymosin beta 4
本发明涉及氧化胸腺素β4在治疗中的应用,尤其是在治疗与炎症反应或感染性休克有关的病症中的应用。本发明也提供含有氧化胸腺素β4和适宜赋型剂的药物制剂。 The present invention relates to use of oxidised thymosin beta 4 in therapy, more particularly in the treatment of diseases or conditions associated with an inflammatory response or septic shock. The present invention also pr...
Saved in:
Main Authors | , , |
---|---|
Format | Patent |
Language | Chinese English |
Published |
08.12.2004
|
Edition | 7 |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | 本发明涉及氧化胸腺素β4在治疗中的应用,尤其是在治疗与炎症反应或感染性休克有关的病症中的应用。本发明也提供含有氧化胸腺素β4和适宜赋型剂的药物制剂。
The present invention relates to use of oxidised thymosin beta 4 in therapy, more particularly in the treatment of diseases or conditions associated with an inflammatory response or septic shock. The present invention also provides pharmaceutical formulations comprising oxidised thymosin beta 4 together with a suitable excipient. |
---|---|
Bibliography: | Application Number: CN19998005957 |